Next Article in Journal
Comparison of Widely Targeted Metabolomics and Untargeted Metabolomics of Wild Ophiocordyceps sinensis
Next Article in Special Issue
Phytochemical Investigation of Cordia africana Lam. Stem Bark: Molecular Simulation Approach
Previous Article in Journal
Editorial to the Special Issue: “Synthesis of Organic Ligands and Their Metal Complexes in Medicinal Chemistry”
Previous Article in Special Issue
Investigation of Chemical Compositions and Biological Activities of Mentha suaveolens L. from Saudi Arabia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Structural Characterization and In-Vitro Antioxidant and Immunomodulatory Activities of Polysaccharide Fractions Isolated from Artemisia annua L.

1
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
2
Beijing Institute of Chinese Medicine, Beijing 100010, China
3
School of Science, Parramatta Campus, Western Sydney University, Locked Bag 1797, Penrith, NSW 2751, Australia
4
Wentworth Institute, 302-306 Elizabeth Street, Surry Hills, NSW 2010, Australia
5
Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Sydney, NSW 2145, Australia
6
Discipline of Paediatrics and Child Health, The Children’s Hospital at Westmead, The University of Sydney, Sydney, NSW 2145, Australia
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(11), 3643; https://doi.org/10.3390/molecules27113643
Submission received: 7 May 2022 / Revised: 30 May 2022 / Accepted: 31 May 2022 / Published: 6 June 2022

Abstract

:
Arimisia annua L. is an important anticancer herb used in traditional Chinese medicine. The molecular basis underpinning the anticancer activity is complex and not fully understood, but the herbal polysaccharides, broadly recognised as having immunomodulatory, antioxidant and anticancer activities, are potential key active agents. To examine the functions of polysaccharides from A. annua, their immunomodulatory and antioxidant potentials were evaluated, as well as their structural characterization. The water-soluble polysaccharides (AAPs) were fractionated using size-exclusion chromatography to obtain three dominant fractions, AAP-1, AAP-2 and AAP-3, having molecular masses centered around 1684, 455 and 5.8kDa, respectively. The antioxidant potentials of the isolated polysaccharides were evaluated by measuring radical scavenging activities against DPPH (2,2-diphenyl-1-picrylhydrazyl radical), ABTS●+ (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid radical ion), and the OH (hydroxyl radical). AAP-1 displayed high antioxidant activities against these radicals, which were 68%, 73% and 78%, respectively. AAP-2 displayed lower scavenging activities than the other two fractions. Immunostimulatory activities of AAPs were measured using mouse macrophages. The three polysaccharide fractions displayed significant antioxidant activities and stimulated the production of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). AAP-1 showed significant immunostimulatory activity (16-fold increase in the production of IL-6 compared to the control and 13-fold increase in the production of TNF-α) with low toxicity (>60% cell viability at 125 μg/mL concentration). Preliminary structural characterization of the AAPs was carried out using gas chromatography (GC) and FTIR techniques. The results indicate that AAP-1 and AAP-2 are pyranose-containing polysaccharides with β-linkages, and AAP-3 is a β-fructofuranoside. The results suggest that these polysaccharides are potential candidates for immunotherapy and cancer treatment.

1. Introduction

Artemisia L. (Asteraceae) is one of the largest and most diverse genus of plants, consisting of more than 500 species and is mainly found in Asia, Europe and North America [1]. Many of these plants are widely used for medicinal purposes [1,2], such as treatment of cancer, malaria, hepatitis, inflammation and infections caused by fungi, bacteria and viruses [3].
Traditionally, Artemisia annua (Asteraceae) is an alternative source of nutrients for humans and livestock and is found in the northern parts of China [3]. The stems were also traditionally used in Chinese medicine for preventing malaria and enhancing immunity in patients [4,5,6,7,8,9,10,11]. A. annua also displayed anticancer activities against various tumors in vitro and in vivo, as well as exhibiting significant synergistic effects with several clinical anti-tumor medicines [6,12]. Several bioactive compounds have been isolated from A. annua, which include sesquiterpenoids, flavonoids, coumarins, triterpenoids, steroids, phenolics, purines and lipids [7,13,14,15,16,17,18]. The plant gained even greater attention after Professor Youyou Tu won the Nobel Prize in 2015 for discovering the antimalarial sesquiterpenoid, artemisinin from A. annua [4,5].
Natural polysaccharides are ideal candidates for developing novel anticancer agents due to their biological activities [19,20,21,22,23,24,25]. However, limited scientific literature exists on polysaccharides isolated from Artemisia [26,27]. Polysaccharides isolated from A. apiacea displayed significant immunomodulatory and anticancer activity [28], polysaccharide (ASKP-1) from A. sphaerocephala exhibited immune enhancing capacity [29], and an inulin-type fructan from A. japonica displayed significant anti-arthritic effects [30]. There are a few recent studies on polysaccharides from A. annua [26,27]. A water-soluble polysaccharide extract was reported to display significant anti-tumor activity, which inhibited HepG2 cell growth by inducing caspase-dependent mitochondrial apoptosis and inhibited NF-κB p65 [27]. The homogeneous polysaccharides from A. annua displayed significant anticomplement activities [26]. To the best of our knowledge, there is limited study involving polysaccharides from A. annua in modulating the immune system.
Preliminary studies carried out in the authors’ laboratory strongly indicated that A. annua has good potential as a source of immunomodulatory and anticancer polysaccharides [31]. The study involved hot water extraction of crude polysaccharides from several Traditional Chinese Medicinal (TCM) herbs, and evaluation of their biological activities with a view to identify the best herbs for further detailed study. The study [31] indicated that A. annua was the herb of choice for the isolation of pure polysaccharides and to study their immunomodulatory potential. This paper describes the aqueous extraction and fractionation (based on molecular weight) of polysaccharides from A. annua and the evaluation of the antioxidant and immunomodulatory activities of each fraction. Appropriate modulation of the immune system and reducing oxidative stress by the polysaccharides are key considerations when formulating anticancer treatment protocols. Hence, we have evaluated the immunomodulatory and antioxidant potentials of these polysaccharides. Structural characterization of these polysaccharides has also been carried out to further understand their structure–activity relationship and mechanisms of action.

2. Results and Discussion

2.1. Fractionation and Purification of Polysaccharides from A. annua

Polysaccharides were extracted from A. annua (AAPs) and fractionated by Sepharose CL-6B size-exclusion chromatography. The detailed procedure for the extraction of polysaccharides and their fractionation is shown in Figure 1 [21,32]. Three fractions were selected based on the total sugar profile of the fractions (Figure 2) obtained by the phenol-sulfuric acid method. These crude polysaccharide fractions were designated as AAP-1, AAP-2, and AAP-3. The profile presented in Figure 2 also gives the protein profile of the fractions (Red trace). AAP-1 displayed the highest sugar content and the other two fractions had relatively low sugar content.
The results for carbohydrate and protein contents in each of the fractions are presented in Table 1. Highest carbohydrate content was observed in AAP-1 (51.8%), followed by AAP-3 (26.3%) and least carbohydrate content was observed in AAP-2 (21.9%). Using the calibration curve obtained from the analysis of dextran molecular weight standards (Figure 3), the average molecular masses of the three fractions, AAP-1, AAP-2 and AAP-3 were determined. The molecular mass of AAP-1 was relatively large, with an estimated average of 1684 kDa, followed by AAP-2 and AAP-3 at 455 and 5.8 kDa, respectively (Figure 3). Table 1 shows the total sugar, protein and monosaccharide content of the three fractions. AAP-1 consists mainly of arabinose (33.35%), glucose (8.69%) and galactose (30.92%), whereas AAP-2 is made up of arabinose (36.02%), glucose (22.16%), mannose (18.17%) and galactose (16.07%) and AAP-3 is mannose (53.08%) and glucose (46.92%). It should be noted that the reduction of fructose yields mannitol and glucitol during GC sample preparation [30,32,33], so it is possible that AAP-3 might be 100% fructose. This aspect is discussed along with the FTIR results. AAP-1 and AAP-2 consist primarily of glucose, galactose, mannose and arabinose.

2.2. FTIR Spectroscopic Characterisation of Active Polysaccharides

Figure 4 presents the FTIR spectra of A. annua polysaccharides (AAP-1, AAP-2 and AAP-3). The spectrum of AAP-1 showed peaks corresponding to β-glycosidic linkage (914–891 cm−1) (Figure 4a) [21,34,35]. The spectrum of AAP-1 also showed three strong absorption bands at 1017.51, 1047.01 and 1074.10 cm−1 (corresponding to C-O stretching vibrations related to glycosidic linkage), indicating the presence of pyranose sugar in AAP-1 [21,34,35]. The rest of the vibrational bands conform to a polysaccharide structure. The broad band centered at 3394.25 cm−1 corresponds to the hydroxyl stretching vibrations of the polysaccharide and the peak at 2934.07 cm−1 belongs to C-H stretching vibrations [21,35]. These observations lead to the conclusion that AAP-1 contains pyranose sugars with β-glycosidic linkages.
The spectrum of AAP-2 (Figure 4b) has a peak at 914 cm−1, indicating the presence of β-glycosidic linkage [21,35]. The three strong absorption peaks in the range 1025–1072 cm−1 (corresponding to C-O stretching vibrations related to glycosidic linkage) indicate the presence of pyranose sugar [21,35]. The broad band centered at 3339 cm−1 corresponds to hydroxyl stretching vibrations and the peak at 2944 cm−1 belongs to C-H stretching vibrations. These observations confirm that AAP-2 contains pyranose sugars with β-glycosidic linkages.
The FTIR spectrum of AAP-3 (Figure 4c) is distinctly different compared to that of AAP-1 and AAP-2. In particular, the region between 815–1025 cm−1 shows different structural features for AAP-3. The peaks at 873 and 815 cm−1 indicate the presence of α- as well as β-glycosidic linkages [21,35]. Two strong absorption peaks in the range of 1000–1100 cm−1 (corresponding to C-O stretching vibrations related to glycosidic linkage) indicate the presence of furanose sugars in AAP-3 [21,35]. It is important to note the absence of pyranose sugars in AAP-3 (as there are only two strong absorption bands in the range of 1000–1100 cm−1). These spectral features together with the GC findings strongly indicate that AAP-3 is a fructan (Figure 4c) [21,35]. The broad band centered at 3280.6 cm−1 corresponds to hydroxyl stretching vibrations of the polysaccharide and the peaks at 2929 and 2889 cm−1 belong to the C-H stretching vibrations. These observations indicate that AAP-3 mainly contains furanose sugars with α- and β-glycosidic linkages. These findings together with the results presented in the author’s preliminary paper [32] for LCP-2 indicates that AAP-3 may be a β-fructofuranan. It will be interesting to study the detailed structure of AAP-3 using NMR spectroscopy. This was not possible in this study as the size exclusion separation gave a very small quantity of this fraction.

2.3. Antioxidant Activities of AAPs

The results of the free radical scavenging capacity of these polysaccharide fractions are presented in Figure 5. The three fractions displayed significant DPPH and ABTS●+ radical scavenging capacities (Figure 5A,B). The most active fraction against DPPH was AAP-1 (68%) at a concentration of 1000 μg/mL, and the least active was AAP-3 (47%) at 1000 μg/mL. The trend against ABTS●+ radical was similar to AAP-1, displaying 73% activity, whereas AAP-3 was 59% at 1000 μg/mL concentration. The EC50 value for DPPH radical scavenging activity of AAP-1 was about 426 µg/mL, followed by AAP-2 (845 µg/mL) and AAP-3 (1392 µg/mL). The EC50 value for ABTS radical scavenging activity of AAP-1 was about 392 µg/mL, followed by AAP-2 (553 µg/mL) and AAP-3 (798 µg/mL). The hydroxyl (OH) radical scavenging abilities of the polysaccharides are presented in Figure 5C. AAP-1 showed extremely high OH scavenging activity (more than 70%), followed by AAP-2, whereas AAP-3 was the least active at 1000 μg/mL concentration. The EC50 value for the hydroxyl (OH) radical scavenging ability of AAP-1 was about 630 µg/mL. However, the antioxidant activities of the polysaccharides are lower than the activity of ascorbic acid (Figure 5).
Literature reports indicate that various factors can influence the antioxidant capacities of botanical polysaccharides [34,36,37]. Major factors that contribute to enhanced activity are (i) higher average molecular weight (more than 90 kDa) for antioxidant activity [37], (ii) presence of β-glycosidic linkages [32,37], (iii) presence of large quantities of glucose, galactose, rhamnose and arabinose within the polysaccharide structure [34,36,37], and (iv) presence of protein or peptide conjugation to the polysaccharide chain increases the radical scavenging ability [21,37].
The results presented in this research are in good agreement with those reported in the literature [34,36,37]. For example, AAP-1 with highly significant antioxidant activity has (i) high average molecular weight (Figure 3), (ii) contains β-glycosidic linkages (Figure 4a), (iii) has protein conjugation (29% protein content) and (iv) contains glucose, galactose, rhamnose and arabinose (Table 1).

2.4. Immunomodulatory Effects of Polysaccharides from A. annua

Immunomodulatory activities of the three isolated polysaccharide fractions were determined by the treatment of RAW 264.7 macrophages with AAPs, and the results for the production of TNF-α and IL-6 are presented in Figure 6.
The results from Figure 6 show that the AAPs have highly significant immunomodulatory activity as indicated by increasing IL-6 and TNF-α production in a dose-dependent manner (Figure 6). As can be seen from Figure 6C,D, the immunostimulatory activities of AAP-1, AAP-2 and AAP-3 increase sharply when the polysaccharide concentration is greater than 15 µg/mL. Excellent immunostimulatory activities are observed for AAP-1 at 125 µg/mL as indicated by: (i) an over 16-fold increase in the production of IL-6 compared to the control (untreated macrophages) (Figure 6C) and (ii) a nearly 13-fold increase in the production of TNF-α (Figure 6D). Immunostimulatory activities of AAP-2 at 125 µg/mL had: (i) a nearly 8-fold increase in the production of IL-6 compared to the control (untreated macrophages) (Figure 6C) and (ii) a nearly 10-fold increase in the production of TNF-α (Figure 6D). Highly significant immunostimulatory activities were also observed for AAP-3 at 125 µg/mL as indicated by: (i) an over 15-fold increase in the production of IL-6 compared to the control (untreated macrophages) (Figure 6C) and (ii) a more than 12-fold increase in the production of TNF-α (Figure 6D). These observations are very significant and demonstrate that AAP-1, AAP-2 and AAP-3 are highly suitable candidates for stimulating the immune system.
As discussed before, appropriate modulation of the immune system and reducing oxidative stress are the important properties to be considered when designing anticancer therapeutics/formulations [21,22,25,32]. A. annua polysaccharides reported in this research displayed highly significant immunomodulatory and antioxidant activities. It is therefore proposed that AAPs are potential candidates for the development of effective anticancer formulations. Further research in this direction is underway in the authors’ laboratory.
Information from the literature indicates that toll-like receptors (TLR) can recognize and bind with various types of polysaccharides such as protein-polysaccharide complexes, inulins and glucans and activate macrophages to promote cytokine secretion (Figure 7) [38,39]. For instance, high molecular weight polysaccharide–protein complex isolated from Lentinus edodes displayed significant immunomodulatory activities [38].
These observations are consistent with literature findings that plant polysaccharides can display immunomodulatory activities [32,39,40,41].
The structure of AAP-3 (Section 2.2) has been identified as a β-(2→1)-fructan with an average molecular mass of 5.8 kDa. Fructans of this size are known to possess significant immunostimulatory activities [32,40,41]. β-(2→1)-linked fructans with long chain lengths (consisting of 11–60 fructose units) can directly interact with dendritic cells (DCs) (Figure 7) [39]. The toll-like receptors (TLRs) present on DCs and macrophages recognize β-(2→1)-linked fructans (inulin-type fructans) and can activate TLR-2 to stimulate immune response and produce cytokines (such as IL-6, IL-1 and TNF-α) [32,39,40,41]. Fructans mainly activate TLR-2, but also TLR-4 and other TLRs to a lesser extent [40,41]. It has also been recognized that β-fructan chain length is an important factor in this mechanism of action (Figure 7) with long chain lengths favoring better immunostimulatory activity [32,40,41].
Two β-(2→1)-linked fructans (inulin type immunomodulatory fructans) have been discovered in the authors’ laboratory: (i) LCP-2 with an average molecular mass of 5.3 kDa published earlier [32] and (ii) AAP-3 with an average molecular mass of 5.8 kDa. Consistent with the literature [35,36], AAP-3 with a larger molecular mass showed significantly higher immunostimulatory activity than LCP-2 [32].
Abundant literature in this area indicates that immunomodulatory activity plays an important role in cancer treatment [19,20,21,22,23,24,25,26,27,28,29,30,31]. Hence, A. annua polysaccharides isolated in this study are potential anticancer agents and useful for the development of anticancer formulations.

2.5. Cell Viability

The effect of AAP-1, AAP-2 and AAP-3 on the viability of mouse macrophage cells is given in Figure 8. The result that the polysaccharides from A. annua show significant cell viabilities even at the highest concentration (125 µg/mL) used in this study indicate that they have low toxicity. These results are consistent with literature reports that plant polysaccharides are essentially non-toxic [21,25,31,32].

3. Materials and Methods

3.1. Material

Artemisia annua (Qing Hao, aerial part) was purchased from Herbal Life Chinese Herbal Medicine shop, Sydney, Australia. The herbs traded in Australia have approvals from both Australian and Chinese governments. Specifications from the supplier indicate that the plant was harvested at the optimum time for medicinal efficacy.

3.2. Chemicals

The DPPH, ABTS●+, 1,10-phenanthroline, H2O2, dimethyl sulfoxide (DMSO), 95% ethanol, ascorbic acid, trypan blue 0.4%, and lipopolysaccharide (LPS) were purchased from Sigma (Rowville, Australia) and Lomb Scientific Pty Ltd. (Sydney, Australia). The foetal bovine serum (FBS), antibiotics, and Dulbecco’s modified Eagle’s medium (DMEM) with gluMax were purchased from BD Bioscience (USA). The tumor necrosis factor-α (TNF-α) and interleukin (IL-6) (mouse)—ELISA standards and antibodies were also purchased from BD Bioscience.

3.3. Extraction and Fractionation of Polysaccharides from A. annua

To extract the water-soluble compounds, 500 g of dried A. annua was powdered then autoclaved (2000 mL, 121 °C, 2 h). Details of the procedure are similar to that published previously and is described in Figure 1 [21,31,32]. These fractions were collected and concentrated by freeze drying, then stored at −20 °C for further studies.

3.4. Determination of Molecular Weights of Polysaccharide Fractions

Estimation of molecular weights of the purified polysaccharide fractions was done on the basis of the elution volume and molecular weight using a standard dextran series that included T2000 (2000 kDa), T450 (450 kDa), T150 (150 kDa), T70 (70 kDa), T40 (40 kDa), T10 (10 kDa) and glucose at a concentration of 10 mg/mL each for calibrating the Sepharose CL-6B column [21,31,32]. Regression of the standard curve gave a linear equation (with R2 = 0.9882) represented by:
y = −0.2328x + 1.523
which was used to estimate the average molecular weight of the polysaccharides.

3.5. Analysis of Monosaccharides

The total sugar content was measured using the phenol–sulfuric acid method [21,32]. Glucose was used to produce a standard curve for determining the sugar content. Regression of the standard curve gave a linear equation (R2 = 0.9964) represented by:
y = 0.0018x + 0.0374
The total protein content was measured using a modified Lowry’s method, where BSA was used to prepare the standards [21,32] for constructing the standard curve for determining the bound protein. Regression of the standard curve gave a linear equation (R2 = 0.9923) represented by:
y = 0.0017x − 0.0212
The mono-sugar content was determined by gas chromatography (Hewlett Packard 7890B) with FID detection [21,32]. The approach followed to prepare the samples for GC analysis was based on the procedure published previously [21]. Mannose, glucose, galactose, xylose, fucose, rhamnose, arabinose and ribose were used as mono-sugar standards.

3.6. Bioactivity Tests

3.6.1. DPPH Scavenging Assay

The Blois method was employed to determine the DPPH scavenging ability of the polysaccharides and is similar to that described in previous publications [32,42,43].
Free radical scavenging activities of AAPs was evaluated using the equation:
DPPH   scavenging   activity   ( % ) = O D c o n t r o l O D S a m p l e O D c o n t r o l   ×   100 %
where OD of the control is the absorbance of DPPH solution without sample and OD of sample is the test sample (DPPH solution plus test sample or positive control).

3.6.2. ABTS●+ Radical Scavenging Assay

ABTS●+ scavenging ability of the polysaccharides was determined using a published method and is similar to that described in previous publications [32,43].
Free radical scavenging activity of AAPs was evaluated using the equation:
ABTS +   scavenging   activity   ( % ) = O D c o n t r o l O D S a m p l e O D c o n t r o l   ×   100 %
where OD of the control is the absorbance of ABTS solution without sample and OD of sample is the test sample (ABTS solution plus test sample or positive control).

3.6.3. OH Radical Scavenging Assay

The OH scavenging assay was a slightly modified method described by de Avellar et al., (2004) [44]. The procedure is similar to that presented in previous publications [32]. Ascorbic acid (Vc) at a concentration range of 17–1000 μg/mL was the positive control. The OH scavenging ability of AAPs was determined using the equation:
OH   scavenging   activity   ( % ) = O D S a m p l e O D n e g _ c o n t r o l O D b l a n k O D n e g _ c o n t r o l   ×   100 %
where the negative control is the reaction mixture without sample and without ascorbic acid. The blank is the reaction mixture without sample, ascorbic acid and H2O2.

3.6.4. Immunomodulatory Activity Assays

Mouse macrophages (RAW 264.7) were first added to DMEM (culture medium containing 1% antibiotic and 5%FBS) and incubated for 4 days at 37 °C in 5% CO2. The cells were then diluted with the medium to achieve a density of 2 × 105 cells/mL. The procedure is based on the published literature [32].

IL-6 Production

ELISA kit (IL-6, BD Biosciences, San Jose, CA, USA) was used to measure the concentration of IL-6 following the procedure in the manufacturer’s manual [31,32,45,46]. All experiments were conducted in triplicate. Standard IL-6 (mouse) was used to produce a calibration curve that gave the linear equation (R2 = 0.992):
y = 0.0019x + 0.0248
which was then used to determine the concentration of IL-6 produced by the polysaccharide extract.

TNF-α Production

ELISA kit (TNF-α, BD Biosciences, San Jose, CA, USA) was used to measure the concentration of TNF-α following the method provided in the manufacturer’s manual and as previously described [31,32,45,46]. Triplicate measurements were made.
Standard TNF-α (mouse) was used to produce the calibration curve that gave the linear equation (R2 = 0.9867):
y = 0.0015x + 0.067
which was used to determine the concentration of TNF-α produced by the polysaccharide extract.

3.6.5. Determination of Cell Viability by MTT Assay

Viability of macrophage cells (RAW 264.7) was measured using the MTT assay as previously described [31,32]. The absorbance was measured at 595 nm and the fraction of live cells was determined using the equation:
C e l l   v i a b i l i t y   % = O D   o f   s a m p l e O D   o f   p o s   c o n t r o l × 100 %
The positive control was mouse macrophages treated by only DMEM medium (without LPS and sample).

3.7. Fourier Transform Infrared (FTIR) Spectroscopy

A TENSOR II FTIR spectrometer (BRUKER) was used for structural characterization of the AAPs at room temperature (25 °C) [32,34]. All spectra were recorded between 4000–450 cm−1.

3.8. Statistical Analysis

Data is expressed as mean ± standard deviation (SD) values. The group mean was compared using a one-way analysis of variance (ANOVA) and Duncan’s multiple range tests. The statistical difference was considered significant if p < 0.05. All statistical analyses were performed using OriginPro 8.5 and Excel 2016.

4. Conclusions

Three polysaccharide fractions were successfully isolated from the aqueous extract of A. annua (AAP-1, AAP-2 and AAP-3). AAPs isolated from A. annua displayed highly significant immunostimulatory capacities and antioxidant activities. In particular, AAP-1 and AAP-3 have displayed very high immunostimulatory activities and low toxicity, demonstrating that they have high potential as natural immune-enhancing agents.
FTIR results indicate that AAP-1 and AAP-2 are pyranose-containing polysaccharides with β-linkages. GC and FTIR results lead to the conclusion that AAP-3 is a β-fructofuranoside. It is pertinent to further compare the biological activity results and structural features of LCP-2 [32] with those of AAP-3. Both polysaccharides gave very similar mono-sugar ratios, similar FTIR spectral features and very comparable biological activities. These results strongly indicate that AAP-3 is a β-fructan.

Author Contributions

Conceptualization, L.Z., N.R., C.S.K., S.R.K.; Methodology, L.Z., N.R., C.S.K., S.R.K.; Validation, L.Z., N.R.; Formal analysis, L.Z., N.R.; Experimental Investigation, L.Z.; Writing—original draft preparation, L.Z., N.R.; Editing, L.Z., N.R., C.S.K., S.R.K.; Supervision, N.R., C.S.K., S.R.K.; Project administration, N.R.; Funding acquisition, N.R., C.S.K. All authors have read and agreed to the published version of the manuscript.

Funding

The School of Science and National Institute of Complementary Medicine (NICM) have provided funding for this research.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

L.Z. acknowledges the IPRS scholarship from the Western Sydney University and National Institute of Complementary Medicine (NICM) during his PhD candidature. L.Z. also acknowledges the Kai Yip Cho Memorial Scholarship from Cho’s family. The School of Science and National Institute of Complementary Medicine (NICM) have provided funding for this research.

Conflicts of Interest

The authors confirm that they have no conflict of interest to declare for this publication.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Abad, M.J.; Bedoya, L.M.; Apaza, L.; Bermejo, P. The Artemisia, L. genus: A review of bioactive essential oils. Molecules 2012, 17, 2542–2566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Bora, K.S.; Sharma, A. The genus Artemisia: A comprehensive review. Pharm. Biol. 2011, 49, 101–109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Brisibe, E.A.; Umoren, U.E.; Brisibe, F.; Magalhäes, P.M.; Ferreira, J.F.; Luthria, D.; Wu, X.; Prior, R.L. Nutritional characterisation and antioxidant capacity of different tissues of Artemisia annua L. Food Chem. 2009, 115, 1240–1246. [Google Scholar] [CrossRef]
  4. Tu, Y. From Artemisia Annua L. To Artemisinins. The Discovery and Development of Artemisinins and Antimalarial Agents; Tu, Y., Ed.; Academic Press: London, UK, 2017. [Google Scholar]
  5. Efferth, T. From ancient herb to versatile, modern drug: Artemisia annua and artemisinin for cancer therapy. Semin. Cancer Biol. 2017, 46, 65–83. [Google Scholar] [CrossRef]
  6. Zhang, S.; Mo, Z.; Zhang, S.; Li, X. A network pharmacology approach to reveal the underlying mechanisms of artemisia annua on the treatment of hepatocellular carcinoma. Evid. Based Complementary Altern. Med. 2021, 2021, 8947304. [Google Scholar] [CrossRef] [PubMed]
  7. Van der Kooy, F.; Sullivan, S.E. The complexity of medicinal plants: The traditional Artemisia annua formulation, current status and future perspectives. J. Ethnopharmacol. 2013, 150, 1–13. [Google Scholar] [CrossRef] [PubMed]
  8. Song, J.; Hu, Y.; Wang, L.; Ao, C. Ethanol Extract of Artemisia Annua Prevents LPS-Induced Inflammation and Blood–Milk Barrier Disruption in Bovine Mammary Epithelial Cells. Animals 2022, 12, 1228. [Google Scholar] [CrossRef] [PubMed]
  9. Sankhuan, D.; Niramolyanun, G.; Kangwanrangsan, N.; Nakano, M.; Supaibulwatana, K. Variation in terpenoids in leaves of Artemisia annua grown under different LED spectra resulting in diverse antimalarial activities against Plasmodium falciparum. BMC Plant. Biol. 2022, 22, 1–13. [Google Scholar] [CrossRef]
  10. Han, X.; Chen, Z.; Yuan, J.; Wang, G.; Han, X.; Wu, H.; Shi, H.; Chou, G.; Yang, L.; Wu, X.J. Artemisia annua water extract attenuates DNCB-induced atopic dermatitis by restraining Th2 cell mediated inflammatory responses in BALB/c mice. J. Ethnopharmacol. 2022, 291, 115160. [Google Scholar] [CrossRef] [PubMed]
  11. Lv, Z.; Li, J.; Qiu, S.; Qi, F.; Su, H.; Bu, Q.; Jiang, R.; Tang, K.; Zhang, L.; Chen, W.S. The transcription factors TLR1 and TLR2 negatively regulate trichome density and artemisinin levels in Artemisia annua. J. Integr. Plant Biol. 2022, 1–17. [Google Scholar] [CrossRef] [PubMed]
  12. Fu, C.; Zhang, K.; Wang, M.; Qiu, F. Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells. Phytomedicine 2022, 100, 154095. [Google Scholar] [CrossRef]
  13. Abate, G.; Zhang, L.; Pucci, M.; Morbini, G.; Mac Sweeney, E.; Maccarinelli, G.; Ribaudo, G.; Gianoncelli, A.; Uberti, D.; Memo, M.J.B. Phytochemical Analysis and Anti-Inflammatory Activity of Different Ethanolic Phyto-Extracts of Artemisia annua L. Biomolecules 2021, 11, 975. [Google Scholar] [CrossRef] [PubMed]
  14. Liu, H.; Guo, S.S.; Lu, L.; Li, D.; Liang, J.; Huang, Z.H.; Zhou, Y.M.; Zhang, W.J.; Du, S.J. Essential oil from Artemisia annua aerial parts: Composition and repellent activity against two storage pests. Nat. Prod. Res. 2021, 35, 822–825. [Google Scholar] [CrossRef] [PubMed]
  15. Nair, M.S.; Huang, Y.; Fidock, D.A.; Polyak, S.J.; Wagoner, J.; Towler, M.J.; Weathers, P.J. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. J. Ethnopharmacol. 2021, 274, 114016. [Google Scholar] [CrossRef]
  16. Adhikari, B.; Marasini, B.P.; Rayamajhee, B.; Bhattarai, B.R.; Lamichhane, G.; Khadayat, K.; Adhikari, A.; Khanal, S.; Parajuli, N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytother. Res. 2021, 35, 1298–1312. [Google Scholar] [CrossRef]
  17. Elfawal, M.A.; Gray, O.; Dickson-Burke, C.; Weathers, P.J.; Rich, S.M. Artemisia annua and artemisinins are ineffective against human Babesia microti and six Candida sp. Longhua Chin. Med. 2021, 4, 12. [Google Scholar] [CrossRef] [PubMed]
  18. Soni, R.; Shankar, G.; Mukhopadhyay, P.; Gupta, V. A concise review on Artemisia annua L.: A major source of diverse medicinal compounds. Ind. Crops. Prod. 2022, 184, 115072. [Google Scholar] [CrossRef]
  19. Cheng, K.F.; Leung, P.C. General review of polysaccharopeptides (PSP) from C. versicolor: Pharmacological and clinical studies. Cancer Ther. 2008, 6, 117–130. [Google Scholar]
  20. Schepetkin, I.A.; Quinn, M.T. Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 2006, 6, 317–333. [Google Scholar] [CrossRef]
  21. Zhang, L.; Koyyalamudi, S.R.; Reddy, N. Isolation, Characterization, and Biological Activities of Polysaccharides from Medicinal Plants and Mushrooms. In Studies in Nature Products Chemistry, 1st ed.; Atta-Ur-Rahman, F.R.S., Ed.; Elsevier: London, UK, 2014; pp. 117–147. [Google Scholar]
  22. Zhang, L.; Reddy, N. Bioactive Molecules from Medicinal Herbs for Life Threating Diseases. Int. J. Mol. Sci. 2018, 2, 4. [Google Scholar]
  23. Friedman, M. Mushroom Polysaccharides: Chemistry and Antiobesity, Antidiabetes, Anticancer, and Antibiotic Properties in Cells, Rodents, and Humans. Foods 2016, 5, 80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Sugiyama, Y. Polysaccharides. In Immunotherapy of Cancer; Yamaguchi, Y., Ed.; Springer: Tokyo, Japan, 2016; pp. 37–50. [Google Scholar]
  25. Zhang, L.; Li, C.G.; Liang, H.; Reddy, N. Bioactive Mushroom Polysaccharides: Immunoceuticals to Anticancer Agents. J. Nutraceuticals Food Sci. 2017, 2, 6. [Google Scholar]
  26. Huo, J.; Lu, Y.; Xia, L.; Chen, D. Structural characterization and anticomplement activities of three acidic homogeneous polysaccharides from Artemisia annua. J. Ethnopharmacol. 2020, 247, 112281. [Google Scholar] [CrossRef]
  27. Yan, L.; Xiong, C.; Xu, P.; Zhu, J.; Yang, Z.; Ren, H.; Luo, Q. Structural characterization and in vitro antitumor activity of A polysaccharide from Artemisia annua L. (Huang Huahao). Carbohydr. Polym. 2019, 213, 361–369. [Google Scholar] [CrossRef]
  28. Chen, J.; Wang, X.; Liu, C. Anti-tumour effects of polysaccharides isolated from Artemisia Annua L by inducing cell apoptosis and immunomodulatory anti-hepatoma effects of polysaccharides. Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 15–22. [Google Scholar] [CrossRef] [Green Version]
  29. Ren, D.; Lin, D.; Alim, A.; Zheng, Q.; Yang, X. Chemical characterization of a novel polysaccharide ASKP-1 from Artemisia sphaerocephala Krasch seed and its macrophage activation via MAPK, PI3k/Akt and NF-κBsignaling pathways in RAW264. 7 cells. Food Funct. 2017, 8, 1299–1312. [Google Scholar] [CrossRef] [PubMed]
  30. Li, N.; Shi, C.; Shi, S.; Wang, H.; Yan, J.; Wang, S. An inulin-type fructan isolated from Artemisia japonica and its anti-arthritic effects. J. Funct. Foods 2017, 29, 29–36. [Google Scholar] [CrossRef]
  31. Zhang, L.; Khoo, C.S.; Koyyalamudi, S.R.; Jones, E.C.; Reddy, N. Immunostimulatory and anticancer activities of polysaccharides extracted from traditional anticancer Chinese medicinal herbs. Pharmacologia 2018, 9, 18–29. [Google Scholar]
  32. Zhang, L.; Khoo, C.S.; Koyyalamudi, S.R.; Jones, E.C.; Reddy, N. Antioxidant and immunomodulatory activities and structural characterization of polysaccharides isolated from Lobelia chinensis Lour. Pharmacologia 2018, 9, 157–168. [Google Scholar]
  33. Fan, H.; Liu, F.; Bligh, S.A.; Shi, S.; Wang, S. Structure of a homofructosan from Saussureacostus and anti-complementary activity of its sulfated derivatives. Carbohydr. Polym. 2014, 105, 152–160. [Google Scholar] [CrossRef] [PubMed]
  34. Thambiraj, S.R.; Phillips, M.; Koyyalamudi, S.R.; Reddy, N. Antioxidant activities and characterisation of polysaccharides isolated from the seeds of Lupinus angustifolius. Ind. Crops Prod. 2015, 74, 950–956. [Google Scholar] [CrossRef]
  35. Yang, L.; Zhang, L.M. Chemical structural and chain conformational characterization of some bioactive polysaccharides isolated from natural sources. Carbohydr. Polym. 2009, 76, 349–361. [Google Scholar] [CrossRef]
  36. Liu, Y.; Zhou, Y.; Liu, M.; Wang, Q.; Li, Y. Extraction optimization, characterization, antioxidant and immunomodulatory activities of a novel polysaccharide from the wild mushroom Paxillus involutus. Int. J. Biol. Macromol. 2018, 112, 326–332. [Google Scholar] [CrossRef]
  37. Wang, H.; Liu, Y.M.; Qi, Z.M.; Wang, S.Y.; Liu, S.X.; Li, X.; Wang, H.J.; Xia, X.C. An overview on natural polysaccharides with antioxidant properties. Curr. Med. Chem. 2013, 20, 2899–2913. [Google Scholar] [CrossRef]
  38. Jiang, M.H.; Zhu, L.; Jiang, J.G. Immunoregulatory actions of polysaccharides from Chinese herbal medicine. Expert Opin. Ther. Targets 2010, 14, 1367–1402. [Google Scholar] [CrossRef] [PubMed]
  39. Peshev, D.; Van den Ende, W. Fructans: Prebiotics and immunomodulators. J. Funct. Foods 2014, 8, 348–357. [Google Scholar] [CrossRef]
  40. Franco-Robles, E.; López, M.G. Implication of fructans in health: Immunomodulatory and antioxidant mechanisms. Sci. World J. 2015, 2015, 15. [Google Scholar] [CrossRef] [Green Version]
  41. Vogt, L.; Ramasamy, U.; Meyer, D.; Pullens, G.; Venema, K.; Faas, M.M.; Schols, H.A.; de Vos, P. Immune modulation by different types of β2→1-fructans is toll-like receptor dependent. PLoS ONE 2013, 8, e68367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Blois, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  43. Alam, M.N.; Bristi, N.J.; Rafiquzzaman, M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm. J. 2013, 21, 143–152. [Google Scholar] [CrossRef] [Green Version]
  44. de Avellar, I.G.; Magalhães, M.M.; Silva, A.B.; Souza, L.L.; Leitão, A.C.; Hermes-Lima, M. Re-evaluating the role of 1, 10-phenanthroline in oxidative reactions involving ferrous ions and DNA damage. Biochim. Biophys. Acta BBA Gen. Subjects 2004, 1675, 46–53. [Google Scholar] [CrossRef] [PubMed]
  45. Ni, L.J.; Wang, N.N.; Zhang, L.G.; Guo, Y.Z.; Shi, W.Z. Evaluation of the effects of active fractions of chinese medicine formulas on IL-1β, IL-6, and TNF-α release from ANA-1 murine macrophages. J. Ethnopharmacol. 2016, 179, 420–431. [Google Scholar] [CrossRef] [PubMed]
  46. Huo, J.; Wu, J.; Zhao, M.; Sun, W.; Sun, J.; Li, H.; Huang, M. Immunomodulatory activity of a novel polysaccharide extracted from Huangshui on THP-1 cells through NO production and increased IL-6 and TNF-α expression. Food Chem. 2020, 330, 127257. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Flow chart for the extraction of polysaccharides from A. annua [21,32].
Figure 1. Flow chart for the extraction of polysaccharides from A. annua [21,32].
Molecules 27 03643 g001
Figure 2. Gel filtration chromatograms of polysaccharide fractions from A. annua.
Figure 2. Gel filtration chromatograms of polysaccharide fractions from A. annua.
Molecules 27 03643 g002
Figure 3. Calibration curve for the determination of molecular weights of polysaccharides from A. annua based on the elution volume and the molecular mass of standard dextran series of T2000 (2000 kDa), T450 (450 kDa), T150 (150 kDa), T70 (70 kDa), T40 (40 kDa), T10 (10 kDa) and glucose (180 Da) (Note: Kav = (Ve − Vo)/(Vt − Vo), Vo is void volume, Vt is total volume and Ve is elution volume).
Figure 3. Calibration curve for the determination of molecular weights of polysaccharides from A. annua based on the elution volume and the molecular mass of standard dextran series of T2000 (2000 kDa), T450 (450 kDa), T150 (150 kDa), T70 (70 kDa), T40 (40 kDa), T10 (10 kDa) and glucose (180 Da) (Note: Kav = (Ve − Vo)/(Vt − Vo), Vo is void volume, Vt is total volume and Ve is elution volume).
Molecules 27 03643 g003
Figure 4. FTIR spectra of the three fractions from A. annua. (a): AAP-1, (b): AAP-2 and (c): AAP-3.
Figure 4. FTIR spectra of the three fractions from A. annua. (a): AAP-1, (b): AAP-2 and (c): AAP-3.
Molecules 27 03643 g004
Figure 5. Antioxidant activities of polysaccharide fractions of A. annua. (A) DPPH free radical scavenging activity of the AAPs. (B) ABTS free radical scavenging activity of the AAPs. (C) Hydroxyl radical scavenging activity of the AAPs. Results are the mean ± SD of three separate experiments, and all the results were compared with the standard (ascorbic acid).
Figure 5. Antioxidant activities of polysaccharide fractions of A. annua. (A) DPPH free radical scavenging activity of the AAPs. (B) ABTS free radical scavenging activity of the AAPs. (C) Hydroxyl radical scavenging activity of the AAPs. Results are the mean ± SD of three separate experiments, and all the results were compared with the standard (ascorbic acid).
Molecules 27 03643 g005
Figure 6. Effects of A. annua polysaccharides on murine RAW 264.7 macrophages. (A,C): represent interleukin 6 (IL-6) production and (B,D): represent tumor necrosis factor-α (TNF-α) production. * Statistical difference for the positive control (LPS treated group) and the samples was significant, n = 3, p < 0.05. ** Statistical difference for the positive control (LPS treated group) and the samples was significant, n = 3, p < 0.03.
Figure 6. Effects of A. annua polysaccharides on murine RAW 264.7 macrophages. (A,C): represent interleukin 6 (IL-6) production and (B,D): represent tumor necrosis factor-α (TNF-α) production. * Statistical difference for the positive control (LPS treated group) and the samples was significant, n = 3, p < 0.05. ** Statistical difference for the positive control (LPS treated group) and the samples was significant, n = 3, p < 0.03.
Molecules 27 03643 g006
Figure 7. Schematic representation of mechanism of immunostimulatory activity induced by inulin-type fructans (β-D-(2→1)-fructan) of longer chain lengths (Note: Fructans with shorter chains leads to decreased production of cytokines) [40,41].
Figure 7. Schematic representation of mechanism of immunostimulatory activity induced by inulin-type fructans (β-D-(2→1)-fructan) of longer chain lengths (Note: Fructans with shorter chains leads to decreased production of cytokines) [40,41].
Molecules 27 03643 g007
Figure 8. Cell viabilities of isolated polysaccharide fractions from A. annua at different concentrations.
Figure 8. Cell viabilities of isolated polysaccharide fractions from A. annua at different concentrations.
Molecules 27 03643 g008
Table 1. Sugar composition of polysaccharide fractions isolated from A. annua.
Table 1. Sugar composition of polysaccharide fractions isolated from A. annua.
AAP-1AAP-2AAP-3 *
Protein (%)29.5710.959.32
Carbohydrate (%)70.4389.0590.68
Monosaccharide (% ratio)
Rhamnose (%)9.67
Ribose (%)
Fucose (%)
Arabinose (%)33.3536.02
Xylose (%)7.67
Mannose (%)1.4418.1753.09
Galactose (%)30.9216.07
Glucose (%)8.6922.1646.92
Unknown (%)8.267.58
* It should be noted that the reduction of fructose yields mannitol and glucitol during GC sample preparation. It is therefore likely that AAP-3 is 100% fructose.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhang, L.; Reddy, N.; Khoo, C.S.; Koyyalamudi, S.R. Structural Characterization and In-Vitro Antioxidant and Immunomodulatory Activities of Polysaccharide Fractions Isolated from Artemisia annua L. Molecules 2022, 27, 3643. https://doi.org/10.3390/molecules27113643

AMA Style

Zhang L, Reddy N, Khoo CS, Koyyalamudi SR. Structural Characterization and In-Vitro Antioxidant and Immunomodulatory Activities of Polysaccharide Fractions Isolated from Artemisia annua L. Molecules. 2022; 27(11):3643. https://doi.org/10.3390/molecules27113643

Chicago/Turabian Style

Zhang, Lin, Narsimha Reddy, Cheang Soo Khoo, and Sundar Rao Koyyalamudi. 2022. "Structural Characterization and In-Vitro Antioxidant and Immunomodulatory Activities of Polysaccharide Fractions Isolated from Artemisia annua L." Molecules 27, no. 11: 3643. https://doi.org/10.3390/molecules27113643

Article Metrics

Back to TopTop